Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

QUEST DIAGNOSTICS INCORPORATED

(DGX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Quest Diagnostics Incorporated : Q2 Adjusted Earnings, Revenue Rise; Issues Full-Year 2021 Outlook

07/22/2021 | 07:16am EDT


© MT Newswires 2021
All news about QUEST DIAGNOSTICS INCORPORATED
09/14QUEST DIAGNOSTICS INCORPORATED : Media Statement about COVID-19 Testing
PU
09/13CARNIVAL CORPORATION : to Provide Convenient Access to Pre-Board Testing; Guests..
AQ
09/13CARNIVAL CORPORATION : to Provide Convenient Access to Pre-Board Testing
AQ
09/10CARNIVAL & : to Provide Pre-Board COVID-19 Testing at Quest Diagnostics Sites
MT
09/09QUEST DIAGNOSTICS INCORPORATED : Increases 2021 Outlook
MT
09/09QUEST DIAGNOSTICS INCORPORATED : UPDATES OUTLOOK FOR FULL YEAR 2021 (Form 8-K)
PU
09/09QUEST DIAGNOSTICS INC : Other Events, Financial Statements and Exhibits (form 8-..
AQ
09/09QUEST DIAGNOSTICS : Updates Outlook For Full Year 2021
PR
09/09Quest Diagnostics Incorporated Revises Earnings Guidance for the Full Year 20..
CI
09/01QUEST DIAGNOSTICS INCORPORATED : KeyBanc Adjusts Quest Diagnostics' Price Target..
MT
More news
Analyst Recommendations on QUEST DIAGNOSTICS INCORPORATED
More recommendations
Financials (USD)
Sales 2021 9 963 M - -
Net income 2021 1 672 M - -
Net Debt 2021 3 587 M - -
P/E ratio 2021 12,3x
Yield 2021 1,57%
Capitalization 18 910 M 18 910 M -
EV / Sales 2021 2,26x
EV / Sales 2022 2,55x
Nbr of Employees 44 500
Free-Float 53,9%
Chart QUEST DIAGNOSTICS INCORPORATED
Duration : Period :
Quest Diagnostics Incorporated Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QUEST DIAGNOSTICS INCORPORATED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Last Close Price 154,77 $
Average target price 155,53 $
Spread / Average Target 0,49%
EPS Revisions
Managers and Directors
Stephen H. Rusckowski Chairman, President & Chief Executive Officer
Mark J. Guinan Chief Financial Officer & Executive Vice President
Jay G. Wohlgemuth Chief Medical Officer, Senior VP-R&D, Medical
Gabrielle Wolfson SVP, Chief Information & Digital Officer
Michael E. Prevoznik General Counsel, Senior VP-Legal & Compliance